[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmaWatch [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) on x XXX followers Created: 2025-07-21 15:45:09 UTC $ALKS [26.50$] [-9.31%] [July 21, 2025] Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type X XXX engagements  **Related Topics** [$alks](/topic/$alks) [Post Link](https://x.com/Biopharma_Watch/status/1947321959748075912)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmaWatch @Biopharma_Watch on x XXX followers
Created: 2025-07-21 15:45:09 UTC
$ALKS [26.50$] [-9.31%] [July 21, 2025] Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type X
XXX engagements
Related Topics $alks
/post/tweet::1947321959748075912